Skip to main content
SpringerLink
Log in

Generic carve-outs would increase costs by $US29b over next decade

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Pharmaceutical Care Management Association.New PCMA Research: State Legislative Proposals Restricting Access to Generic Medicines Would Increase Costs $29 Billion Over 10 Years. Media Release: 3 Oct 2008. Available from: URL: http://pcmanet.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Generic carve-outs would increase costs by $US29b over next decade. Pharmacoecon. Outcomes News 564, 9 (2008). https://doi.org/10.2165/00151234-200805640-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805640-00023

Keywords

Search

Navigation